Cannabis composition

1. A pharmaceutical composition comprising a Cannabis extract and optionally one or more pharmaceutically acceptable carriers, diluents, adjuvants, excipients or any combination thereof, the Cannabis extract comprising a cannabinoid fraction and a terpene fraction, wherein the Cannabis extract comprises:

A:

≥0.3% w/w of the terpene fraction;

≥50% w/w Δ 9 -Tetrahydrocannabinol (THC);

≥0.3% w/w Cannabigerol (CBG); and

≤0.5% w/w Cannabinol (CBN);

wherein the terpene fraction comprises:

ß-caryophyllene in an amount of at least 11% by weight of the terpene fraction,

linalool in an amount of at least 5% by weight of the terpene fraction; and

ß-pinene in an amount of at least 1% by weight of the terpene fraction.

2. The pharmaceutical composition of claim 1 , wherein the Cannabis extract is a Cannabis oil.

3. The pharmaceutical composition of claim 1 , wherein, for composition A, the Cannabis extract comprises Δ 9 -tetrahydrocannabinol (THC) in an amount of from 50% to 99% by weight of the pharmaceutical composition.

4. The pharmaceutical composition of claim 1 , wherein the Cannabis extract comprises one or more additional cannabinoids selected from Δ 9 -Tetrahydrocannabinolic acid (THCA), Δ 9 -Tetrahydrocannabivarin (THCV), and (−)-Cannabidivarin (CBDV).

5. The pharmaceutical composition of claim 1 , wherein the terpene fraction further comprises one or more of ß-myrcene, D-limonene, a nerolidol and α-pinene.

6. The pharmaceutical composition of claim 1 , wherein the terpene fraction further comprises one or more of α-bisabolol, caryophyllene oxide, p-cymene, isopulegol, ocimene, α-terpinene, γ-terpinene, δ-s-carene, guaiol, and terpinolene.

7. The pharmaceutical composition of claim 1 , wherein the pharmaceutically acceptable carrier is sesame oil.

8. The pharmaceutical composition of claim 1 , further comprising an active agent other than the Cannabis extract.

9. The pharmaceutical composition of claim 1 for treating cancer or a symptom associated with cancer.